Supplemental figure 3 from Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum
Alicia Hulbert(Johns Hopkins University), James G. Herman(UPMC Hillman Cancer Center), Andrew Yang, Stephen B. Baylin(Johns Hopkins University), Tza‐Huei Wang(Johns Hopkins University), Ignacio Jusué-Torres(Johns Hopkins University), Alejandro Stark(Johns Hopkins University), Steven A. Belinsky(Lovelace Respiratory Research Institute), John Wrangle(Johns Hopkins University), Chen Chen(Hangzhou Medical College), Peng Huang(Wildlife Conservation Society), Malcolm V. Brock(Johns Hopkins University), Stephen C. Yang, Kristen Rodgers(Johns Hopkins University), Candace Griffin(Johns Hopkins University), Beverly Lee(Lovelace Respiratory Research Institute)
Cited by 0
Related Papers
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
The biology and role of CD44 in cancer progression: therapeutic implications
|Journal of Hematology & Oncology|2018|1.4k